Martha discusses her recent research on Parkinson's animal models using lipopolysaccharide (LPS) to induce Parkinson's symptoms in mice, a recent Cambridget hypothesis paper on LPS as a cause of Parkinson's and her company's microbiome research connecting to Gram negative, LPS producing gut bacteria.  She also discusses her recent BiotiQuest Sugar Shift clinical trial in diabetes showing the reduction of serum LPS endotoxin over the three month trial.   LPS blog. https://www.marthasquest.com/post/rethinking-parkinson-s-disease-1 Biotiquest Sugar Shift  Clinical trial paper - Metabolic shifting probiotic in Type 2 Diabetes  www.thebiocollective.com Weston Price GcMAF raw milk yogurt